Business Wire

Microsoft, SES and GRC Showcase Azure Cloud for Remote Missions via Secure GovSat Connectivity Service

30.6.2021 09:50:00 EEST | Business Wire | Press release

Share

Microsoft and SES, in partnership with GovSat and UK-based solutions provider GRC, came together to demonstrate how Microsoft Azure Machine Learning (ML) and Artificial Intelligence (AI) capabilities can be brought directly to end-users deployed globally in a highly secure, reliable way while maintaining network sovereignty - allowing users to exploit key Azure workloads regardless of location and drastically boosting the efficiency of critical missions.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210629006127/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Microsoft, SES and GRC Showcase Azure Cloud for Remote Missions via Secure GovSat Connectivity Service (Photo: Business Wire)

In these demonstrations the Azure Stack Mini R device was connected to a quick deployable tactical satcom terminal from GRC through the secure SATCOM connection on GovSat-1 satellite, and sent directly to Azure UK via the SES Cloud Direct service, giving connected and disconnected access to Azure services.

The first demonstrations of its kind highlighted how this technology could be used in a number of scenarios such as a remote disaster relief operation, collecting information for analysis, at any given classification, allowing AI and ML models to be used to categorise and assess the information locally before using the available SATCOM to update the overall situational awareness picture and, if required, updating the AI and ML models via hyperscale Azure DevOps processes.

“SES’s high-performance satellite network enables an important demonstration of secure cloud computing at the edge,” said Tom Keane, Corporate Vice President, Azure Global, Microsoft. “Together with our technology partners, Microsoft is bringing mission-driven customers the latest services they require in a secure and reliable way, regardless of the infrastructure available. This approach empowers mission owners and operators in both connected and disconnected environments, while giving governments total flexibility and control over their data.”

“Governments are looking to accelerate cloud adoption and extend it to the edge bringing its advantages to the end-users anywhere. We are proud that through our partnerships with Microsoft and GovSat, we have managed to demonstrate the security and performance of the network, alongside the required high degree of flexibility for the government customers,” said JP Hemingway, CEO of SES Networks. “Similarly, the same secure high-performance cloud communications services can be achieved on our MEO satellites, independent of the internet and other publicly accessible networks.”

“Utilising single-hop secure cloud communication between the headquarters and deployed teams, which is closed to publicly accessible ground stations and internet touchpoints, opens multiple opportunities for governments. The GRC’s solution together with the Microsoft Azure cloud service and SES’s secure resilient satellite networked connectivity makes the future of cloud-enabled government communications a reality already today,” said Steve Slater, Managing Director at GRC.

The demo is highly scalable thanks to the Azure Edge capability, as well as the wide array of SES’s satellite communications capabilities, including next-generation O3b mPOWER system that is capable of providing from Mbps to multiple Gbps connectivity for land, air and maritime government missions.

Further Information
The first demonstration showcased one-hop connectivity that enables cloud workloads to run at the edge and seamlessly connect back to hyperscale Azure in both connected and disconnected modes via the Azure Stack Edge Mini R.

For this demonstration, the companies leveraged multiple satellite terminals from GRC’s 6-SAT solution, GovSat’s dedicated Military Ka-band beam onboard its satellite and GovSat’s secure Mission Operations Centre in Luxembourg.

The second demonstration was performed with GRC’s deployable Satellite Ground Station (SGS), showcasing in-theatre connectivity as well as backhaul of data from in-theatre headquarters to the home country with no public internet touchpoints. The first satellite link was securely connecting a deployed terminal with the in-theatre headquarters terminal, and anchored directly to the deployable, private SGS hub. The second satellite link connecting the deployable SGS hub was anchored in the GovSat Mission Operations Centre, demonstrating backhauling to a home country.

The SES Cloud Direct service was delivered via a dedicated Microsoft ExpressRoute connection directly from the end-users to Azure data centres, enabling the cloud agility and performance via a dedicated MilSatCom GEO capability. For low-latency applications, SES can also bring the data from the edge to the cloud in a safe, secure and efficient way through its high-throughput low-latency O3b satellite network and its upcoming next-generation cloud-scale O3b mPOWER system, both operating in medium earth orbit (MEO).

Follow us on:

Twitter, Facebook, YouTube, LinkedIn, Instagram

Read our Blogs >
Visit the Media Gallery >

About SES
SES has a bold vision to deliver amazing experiences everywhere on earth by distributing the highest quality video content and providing seamless connectivity around the world. As the leader in global content connectivity solutions, SES operates the world’s only multi-orbit constellation of satellites with the unique combination of global coverage and high performance, including the commercially-proven, low-latency Medium Earth Orbit O3b system. By leveraging a vast and intelligent, cloud-enabled network, SES is able to deliver high-quality connectivity solutions anywhere on land, at sea or in the air, and is a trusted partner to the world’s leading telecommunications companies, mobile network operators, governments, connectivity and cloud service providers, broadcasters, video platform operators and content owners. SES’s video network carries over 8,200 channels and has an unparalleled reach of 361 million households, delivering managed media services for both linear and non-linear content. The company is listed on Paris and Luxembourg stock exchanges (Ticker: SESG). Further information is available at: www.ses.com.

About GRC
GRC is a Hereford (UK) based company delivering fully managed, Satcom as a Service (6-SAT), RF, cloud and IP connectivity solutions to Defence, Government, Emergency Response and Commercial sectors. Its partnerships and Tier-1 VAR (Value-Added Reseller) status with leading hardware and airtime providers ensure cost-effective, intelligently integrated solutions, backed up by through life support and training.

About GovSat
GovSat is a public private partnership between the Government of Luxembourg and the world-leading satellite operator SES. GovSat’s mission is to provide secure, reliable and accessible governmental satellite communication services to address the demand resulting from defence and institutional security applications. The company’s first satellite GovSat-1 is a multi-mission satellite that will use X-band and Military Ka-band frequencies on high-power and fully steerable mission beams to support multiple operations. For more information visit: www.govsat.lu

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Suzanne Ong
External Communications, SES
Tel. +352 710 725 500
suzanne.ong@ses.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye